CLEARWATER, FL--(Marketwire - August 28, 2012) - Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, The Company), a fully reporting public company in the stem cell regenerative medicine sector, announced today that, in response to overwhelming inquiries from hair clinics around the nation, it has completed preparation to allow for expansion of hair regrowth services throughout the United States.
According to Dwight Brunoehler, Chief Executive Officer of Bisotem, "On the heels of Dr. Marina Pizarro's initial hair replacement procedures using The Biostem Method™, the Company is now fully prepared to offer and support turnkey operations that will provide its proprietary hair regrowth technology to qualified physicians and clinics in the U.S. This service provides equipment, on site set up, training, operational protocols, marketing assistance, a fully staffed training facility, and on-going support. Our intention is to make this as easy as possible for affiliates to become involved. After entering into an agreement, physicians will be able to offer Biostem services in their offices within 8 weeks. It is expected that hair replacement clinics in New York, California, Texas and other metropolitan centers known for the popularity of cosmetic procedures will be on board The Biostem Method™ before the end of the year."
Biostem U.S., Corporation has developed a hair restoration process known as The Biostem Method™. This process, offered through Biostem affiliates and licensees, involves the use of platelet rich plasma injections, low level laser therapy, nutraceutical supplements to stimulate stem cell growth, and private labeled hair products. This combination has proven highly effective in restoring hair growth in men and women.
About Biostem U.S., Corporation
Biostem U.S., Corporation is a fully reporting Nevada corporation with offices in Clearwater, Florida. Biostem is a technology licensing company with proprietary technology centered on providing hair regrowth using human stem cells. The company also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body's natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient's own stem cells. Biostem U.S. is seeking to expand its operations worldwide through licensing of its proprietary technology and acquisition of existing stem cell related facilities. The company's goal is to operate in the international biotech market, focusing on the rapidly growing regenerative medicine field, using ethically sourced adult stem cells to improve the quality and longevity of life for all mankind.
More information on Biostem U.S., Corporation can be obtained through www.biostemus.com, or by calling Fox Communications Group, 310-974-6821.